PMC:7652766 / 28594-28881 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T49","span":{"begin":32,"end":41},"obj":"Phenotype"},{"id":"T50","span":{"begin":48,"end":54},"obj":"Phenotype"},{"id":"T51","span":{"begin":59,"end":67},"obj":"Phenotype"}],"attributes":[{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0002018"},{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0002013"}],"text":"cted with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascular diseases and impaired consciousness (26,"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1129","span":{"begin":10,"end":20},"obj":"Species"},{"id":"1130","span":{"begin":121,"end":129},"obj":"Species"},{"id":"1131","span":{"begin":169,"end":177},"obj":"Species"},{"id":"1132","span":{"begin":74,"end":75},"obj":"Gene"},{"id":"1139","span":{"begin":32,"end":41},"obj":"Disease"},{"id":"1140","span":{"begin":48,"end":54},"obj":"Disease"},{"id":"1141","span":{"begin":59,"end":67},"obj":"Disease"},{"id":"1142","span":{"begin":112,"end":120},"obj":"Disease"},{"id":"1143","span":{"begin":154,"end":168},"obj":"Disease"},{"id":"1144","span":{"begin":231,"end":255},"obj":"Disease"},{"id":"1145","span":{"begin":260,"end":282},"obj":"Disease"}],"attributes":[{"id":"A1129","pred":"tao:has_database_id","subj":"1129","obj":"Tax:2697049"},{"id":"A1130","pred":"tao:has_database_id","subj":"1130","obj":"Tax:9606"},{"id":"A1131","pred":"tao:has_database_id","subj":"1131","obj":"Tax:9606"},{"id":"A1132","pred":"tao:has_database_id","subj":"1132","obj":"Gene:351"},{"id":"A1139","pred":"tao:has_database_id","subj":"1139","obj":"MESH:D006261"},{"id":"A1140","pred":"tao:has_database_id","subj":"1140","obj":"MESH:D009325"},{"id":"A1141","pred":"tao:has_database_id","subj":"1141","obj":"MESH:D014839"},{"id":"A1142","pred":"tao:has_database_id","subj":"1142","obj":"MESH:C000657245"},{"id":"A1143","pred":"tao:has_database_id","subj":"1143","obj":"MESH:D016638"},{"id":"A1144","pred":"tao:has_database_id","subj":"1144","obj":"MESH:D002561"},{"id":"A1145","pred":"tao:has_database_id","subj":"1145","obj":"MESH:D003244"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"cted with SARS‐CoV‐2 did report headaches (8%), nausea, or vomiting (1%). A more recent study investigating 214 COVID‐19 patients found that about 88% of critically ill patients displayed neurologic manifestations, including acute cerebrovascular diseases and impaired consciousness (26,"}